Madrigal Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Madrigal Pharmaceuticals (Nasdaq: MDGL) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's presentation is scheduled for Wednesday, January 15, 2025, at 2:15 pm PT. Interested parties can access the live webcast through either a direct link or via the Events and Presentations section of Madrigal's Investor Relations website.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, MDGL gained 1.88%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
CONSHOHOCKEN, Pa., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025 at 2:15 pm PT. The presentation will be webcast live and can be accessed here or by visiting Madrigal’s Investor Relations Site, Events and Presentations.
About Madrigal
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. For more information, visit www.madrigalpharma.com.
Investor Contact
Tina Ventura, IR@madrigalpharma.com
Media Contact
Christopher Frates, media@madrigalpharma.com
FAQ
When is Madrigal Pharmaceuticals (MDGL) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch Madrigal Pharmaceuticals' (MDGL) J.P. Morgan Healthcare Conference presentation?
Which annual J.P. Morgan Healthcare Conference will MDGL be presenting at in 2025?
Will Madrigal Pharmaceuticals' (MDGL) J.P. Morgan presentation be available for replay?
